Savara Inc. (SVRA) News
Follow Savara Inc. (SVRA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
BKV, Lamb Weston, Penguin Solutions And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling around 1% on Wednesday. Shares of BKV Corp (NYSE: BKV ) rose sharply after the company announced that a subsidiary executed into a n equipment supply contract. BKV
LIVE | Oct 07, 2026, 02:08 PM UTC
L
Savara announces ERS 2026 encore presentations of Phase 3 APAP results
Savara says it will present encore results from the Phase 3 clinical trial of molgramostim inhalation solution in autoimmune pulmonary alveolar proteinosis at the European Respiratory Society Congress 2026.
EQUITY | Aug 24, 2026, 08:05 PM UTC
M
SVRA: MOLBREEVI MAAs Under Review
Savara says MOLBREEVI MAAs are under review by EMA and U.K.'s MHRA
EQUITY | Aug 11, 2026, 09:01 PM UTC
L
Savara Q2 EPS $(0.16) Misses $(0.14) Estimate
Savara (NASDAQ: SVRA ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 14.29 percent decrease over losses of $(0.14) per share from the sa
EARNINGS | Aug 11, 2026, 08:36 PM UTC
H
Savara: Europe, Australia Grant Molbreevi Patents
Savara gets patents for molbreevi in Europe and Australia
EQUITY | Jul 30, 2026, 12:28 PM UTC